Results 31 to 40 of about 6,793 (233)

Outcomes for Surgery in Stage IA Large Cell Lung Neuroendocrine Compared With Other Types of Non-Small Cell Lung Cancer: A Propensity Score Matching Study Based on the Surveillance, Epidemiology, and End Results (SEER) Database

Frontiers in Oncology, 2020
BackgroundPulmonary large cell neuroendocrine cancer (LCNEC) is commonly classified as non-small cell lung cancer (NSCLC). Even for stage I disease, after surgery the survival is always poor, but clinical research on LCNEC is scant and always with ...
Liqing Zou, Liqing Zou, Tiantian Guo, Tiantian Guo, Luxi Ye, Luxi Ye, Yue Zhou, Yue Zhou, Li Chu, Li Chu, Xiao Chu, Xiao Chu, Jianjiao Ni, Jianjiao Ni, Jianjiao Ni, Zhengfei Zhu, Zhengfei Zhu, Zhengfei Zhu, Xi Yang, Xi Yang   +19 more
doaj   +1 more source

P2-198: Evaluation of postoperative adjuvant chemotherapy for large cell neuroendocrine carcinoma (LCNEC) [PDF]

Journal of Thoracic Oncology, 2007
Rie Nakahara, Haruko Suzuki, Yoshinori Ishikawa, Haruhisa Matsuguma, Tetsuro Kondo, Yukari Kamiyama, Kiyoshi Mori, Seiji Igarashi, Tetsuro Kodama, Kohei Yokoi   +9 more
openalex   +2 more sources

Pulmonary Large Cell Neuroendocrine Carcinoma

Pathology and Oncology Research, 2022
Pulmonary large cell neuroendocrine carcinoma (LCNEC) is a rare subtype of malignant pulmonary tumor. The incidence rate of LCNEC was reported to be 0.3%–3% in lung cancers.
Lan Yang, Lan Yang, Lan Yang, Lan Yang, Ying Fan, Ying Fan, Ying Fan, Ying Fan, Hongyang Lu, Hongyang Lu, Hongyang Lu, Hongyang Lu   +11 more
doaj   +1 more source

A Case of Large-cell Neuroendocrine Carcinoma (LCNEC) with Various Cytology Findings.

Haigan, 1994
田口 浩之, 秋田 弘俊, 竹川 宏典, 阿部 庄作, Takayuki Nojima, 川上 義和   +5 more
openalex   +3 more sources

Molecular Subtypes of High-Grade Neuroendocrine Carcinoma (HGNEC): What is YAP1-Positive HGNEC?

Frontiers in Bioscience-Landmark, 2022
Small cell lung cancer (SCLC) subtype classification, based on high-level expression of key transcriptional regulators; ASCL1 (SCLC-A), NEUROD1 (SCLC-N), POU2F3 (SCLC-P), and YAP1 (SCLC-Y), has recently been proposed.
Hitomi Kawai, Ryouta Matsuoka, Takeshi Ito, Daisuke Matsubara   +3 more
doaj   +1 more source

Genomic subtypes of pulmonary large cell neuroendocrine carcinoma (LCNEC) may predict chemotherapy outcome [PDF]

Annals of Oncology, 2017
Jules L. Derks, Noémie Leblay, Robert Jan van Suylen, Erik Thunnissen, Michael A. den Bakker, Harry J.M. Groen, Egbert F. Smit, Ronald Damhuis, Evert van den Broek, Amélie Charbrier, Matthieu Foll, James McKay, Lynnette Fernandez‐Cuesta, E-J. Speel, Anne‐Marie C. Dingemans   +14 more
openalex   +3 more sources

Breast metastasis and lung large-cell neuroendocrine carcinoma: first clinical observation [PDF]

, 2017
The lung Large-cell neuroendocrine carcinoma (LCNEC) is a very rare aggressive neuroendocrine tumor with a high propensy to metastasize and very poor prognosis.
Di Cristofano, C, Minozzi, M, Moretti, V, Papa, A, Rossi, L, Strudel, M, Tomao, S., Verrico, M, Zoratto, F   +8 more
core   +1 more source

Histologic Transformation of ALK-Rearranged Lung Adenocarcinomas to High-Grade LCNEC: Clinical and Molecular Description of Three Cases [PDF]

Clinical Lung Cancer
Paolo Ambrosini, Daniela Miliziano, Giorgia Di Liberti, Daniele Lorenzini, Silvia Marchesi, A. Bassetti, Elena Tamborini, Rita Leporati, Teresa Beninato, Laura Mazzeo, Marta Brambilla, Monica Ganzinelli, Arsela Prelaj, Claudia Proto, Filippo de Braud, Giuseppe Lo Russo, Mario Occhipinti   +16 more
openalex   +3 more sources

Challenges in Diagnosis and Management of Ovarian Neuroendocrine Carcinoma: A Case of Aggressive Disease With Multimodal Treatment Approach. [PDF]

Clin Case Rep
ABSTRACT Neuroendocrine tumors (NETs) of the ovary are extremely rare, accounting for only 1%–2% of malignant ovarian tumors, with high‐grade subtypes demonstrating particularly aggressive behavior. We describe a 47‐year‐old woman who presented with abdominal swelling, irregular bleeding, and pain, and was diagnosed with high‐grade ovarian ...
Haider J, Mahmood H, Faheem M, Khurshid S, Abdullah, Ayalew BD, Saeed H.   +6 more
europepmc   +2 more sources

Clinicopathological characteristics and prognostic factors of pulmonary large cell neuroendocrine carcinoma: A large population‐based analysis

Thoracic Cancer, 2019
Background The study was conducted to compare the clinicopathological characteristics, survival outcomes, and metastatic patterns between pulmonary large cell neuroendocrine carcinoma (LCNEC) and other non‐small cell lung cancer (ONSCLC), and to identify
Qiao Yang, Zihan Xu, Xiewan Chen, Linpeng Zheng, Yongxin Yu, Xianlan Zhao, Mingjing Chen, Bangyu Luo, Jianmin Wang, Jianguo Sun   +9 more
doaj   +1 more source